As MTX continues to play a central role in the treatment of various malignancies, the balance between its therapeutic efficacy and potential toxicity must be carefully managed. Delayed MTX clearance is associated with an increased risk of AEs,…
The relationship between urine output and time to methotrexate clearance in pediatric leukemia patients receiving high-dose methotrexate therapy | BMC Cancer
